Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WELL-HART: Hormone Replacement Therapy in Postmenopausal Women with Coronary Disease
NCT00000559Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Mar 1995
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of estradiol, medroxyprogesterone acetate in coronary heart disease (CHD), sponsored by National Heart, Lung, and Blood Institute. Started Mar 1995; status: completed.
02
Drugs
estradiolmedroxyprogesterone acetate
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT00000559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000559.